Bengaluru: Practo, Asia’s leading healthcare technology firm, announces the launch of its award winning product ‘Practo Search’ Indonesia. With this, the company will provide the patients in Indonesia with the largest database of verified doctors in the whole country. The users will be able to choose from over 4200 certified doctors in over 60 percent of all clinics in Jakarta using the Practo app or website which will be available both in Indonesian and English languages.
“We are on a mission to help people live better, healthier lives globally. I am thrilled to bring our world class healthcare experience to millions of consumers across Indonesia and the Philippines. Over the next several months, we will continue our global expansion to be present in over 10 countries by March and enable over two billion consumers to make better healthcare decisions,” quotes Shashank ND, Founder & CEO, Practo.
Practo is planning to expand its operations to Jakarta Raya area including Bogor, Depok, Tangerang and Bekasi regions in the next few months. In addition to this, the company is also planning to foray into the Phillipines market to cover Cebu, Cavite & Batangas regions and also extend its product offerings in more healthcare segments like wellness, medicine, fitness and preventive & curative.
Founded by NIT-Karnataka alumni Shashank N D and Abhinav Lal, Practo is a technology firm which enhances the patients’ experience by providing them with a list of clinics and doctors. It maintains an online database of these doctors and the patients can search for their desired doctor and fix an appointment. The company has also developed Practo Ray, a user-friendly online medical practice management software for doctors. Similarly, Practo Hello is another cloud based telephony solution which enables the doctors and patients to connect with each other. Since its inception in 2008, the company claims to have listed over 200,000 healthcare personnel on its portal and sees over 10 million searches every month with over 8000 doctors treating three million patients in India alone. Earlier this year the company had raised $90 million Series C funding round led by Tencent Holdings and $30 million Series B funding from Sequoia Capital and Matrix partners in August and February respectively.